Researchers publish cell protein findings to determine effectiveness of immunotherapy for colon cancer

by Kelley Luckstein,Mayo ClinicCredit: CC0 Public DomainMayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patien

Oncology February 01,2024

Researchers publish cell protein findings to determine effectiveness of immunotherapy for colon cancer

by Kelley Luckstein,Mayo ClinicCredit: CC0 Public DomainMayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patien

Oncology February 01,2024

Novel treatment effective for bladder cancer, study in mice shows

by Northwestern UniversityCredit: Unsplash/CC0 Public DomainAn epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by

Oncology February 01,2024

Novel treatment effective for bladder cancer, study in mice shows

by Northwestern UniversityCredit: Unsplash/CC0 Public DomainAn epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by

Oncology February 01,2024

Researchers pinpoint potential treatment for lethal childhood cancer

by McMaster UniversityCredit: Unsplash/CC0 Public DomainAn enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster Universi

Oncology February 01,2024

Researchers pinpoint potential treatment for lethal childhood cancer

by McMaster UniversityCredit: Unsplash/CC0 Public DomainAn enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster Universi

Oncology February 01,2024

Clinicians supporting cancer patients with taste loss need educational materials and training, finds survey

by University of Massachusetts AmherstParticipants describe important criteria to consider upon developing educational materials to facilitate learning about taste alterations. Credit:Suppo

Oncology February 01,2024

Clinicians supporting cancer patients with taste loss need educational materials and training, finds survey

by University of Massachusetts AmherstParticipants describe important criteria to consider upon developing educational materials to facilitate learning about taste alterations. Credit:Suppo

Oncology February 01,2024

Attenuation of cancer proliferation by suppression of glypican-1

by Impact Journals LLCOverexpression of GPC1 increases proliferation of T24 cells. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28388A new research paper titled "Attenuation of c

Oncology February 01,2024

Attenuation of cancer proliferation by suppression of glypican-1

by Impact Journals LLCOverexpression of GPC1 increases proliferation of T24 cells. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28388A new research paper titled "Attenuation of c

Oncology February 01,2024

Cis-regulatory sequences indicative of nasopharyngeal carcinoma risk identified

by Justin Jackson , Medical XpressCredit:The American Journal of Human Genetics(2023). DOI: 10.1016/j.ajhg.2023.06.003Research led by the Sun Yat-sen University Cancer Center in China has

Oncology February 01,2024

Cis-regulatory sequences indicative of nasopharyngeal carcinoma risk identified

by Justin Jackson , Medical XpressCredit:The American Journal of Human Genetics(2023). DOI: 10.1016/j.ajhg.2023.06.003Research led by the Sun Yat-sen University Cancer Center in China has

Oncology February 01,2024

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi

Oncology February 01,2024

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi

Oncology February 01,2024

Researchers discover a new mechanism of cancer immune defense

by Universitätsmedizin MagdeburgGraphical summary of inflammatory cell death induction of MHC-deficient and IFN-unresponsive tumors by CD4+ T cells in cooperation with iNOS-expressing myeloid cells. C

Oncology February 01,2024

Researchers discover a new mechanism of cancer immune defense

by Universitätsmedizin MagdeburgGraphical summary of inflammatory cell death induction of MHC-deficient and IFN-unresponsive tumors by CD4+ T cells in cooperation with iNOS-expressing myeloid cells. C

Oncology February 01,2024

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Oncology February 01,2024

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Oncology February 01,2024

England moves to a single-dose HPV vaccine

by Cancer Research UKCredit: Cancer Research UKThe HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Oncology February 01,2024

England moves to a single-dose HPV vaccine

by Cancer Research UKCredit: Cancer Research UKThe HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Oncology February 01,2024